Loading…
AIM ImmunoTech Inc. is projected to rise to $0.2814 by 2027, a +7% move from its current price of $0.264. AIM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.2502 | $0.2641 | $0.2787 | +0.02% |
| Aug 6 | $0.2447 | $0.2641 | $0.2851 | +0.04% |
| Aug 7 | $0.2405 | $0.2642 | $0.2901 | +0.06% |
| Aug 8 | $0.2371 | $0.2642 | $0.2944 | +0.08% |
| Aug 9 | $0.2342 | $0.2643 | $0.2983 | +0.10% |
| Aug 10 | $0.2315 | $0.2643 | $0.3018 | +0.13% |
| Aug 11 | $0.2291 | $0.2644 | $0.3051 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2291 | $0.2644 | $0.3051 | +0.15% |
| Week 2 | $0.2163 | $0.2648 | $0.3242 | +0.29% |
| Week 3 | $0.2069 | $0.2652 | $0.3398 | +0.44% |
| Week 4 | $0.1995 | $0.2656 | $0.3536 | +0.59% |
| Week 5 | $0.1931 | $0.2659 | $0.3662 | +0.74% |
| Week 6 | $0.1876 | $0.2663 | $0.3782 | +0.88% |
| Week 7 | $0.1827 | $0.2667 | $0.3895 | +1.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.
Its flagship products include Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts.
The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.
Symbol AIM; current price $0.2536. Market cap $7.03M. Rank 5182.
The price outlook shows gradual upside with a 2026 average price of $0.2536 and a 2050 average of $0.7582, and a 2050 maximum of $1.74.
The forecast sentiment is NEUTRAL in 2026 and 2027, turning BULLISH from 2028 onward, with progressively higher averages and ROIs by later years.
A major floor 43.2% below — a decisive break under it would weaken the trend.
The nearest floor, 9.1% below — buyers have tended to step in here.
The nearest ceiling, 43.9% above — a clean break opens room to run.
A major ceiling 267.4% above — clearing it would confirm fresh momentum.
Key AIM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AIM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.244 | Buy | $0.2456 | Buy |
| MA 10 | $0.247 | Buy | $0.2503 | Buy |
| MA 20 | $0.2635 | Buy | $0.2701 | Sell |
| MA 50 | $0.356 | Sell | $0.347 | Sell |
| MA 100 | $0.4666 | Sell | $0.5676 | Sell |
| MA 200 | $0.9348 | Sell | $1.88 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.92 | Neutral |
| Stoch RSI (14) | 86.40 | Sell |
| CCI (20) | -52.33 | Neutral |
| Williams %R (14) | -66.67 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -3.85 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 33.33 | Neutral |
| TRIX (15) | -1.61 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 42.04 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.24 | Buy |
| ADX (14) | 22.88 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40 and the SMA50 is $0.356 while the SMA200 is $0.9348.
Support is at $0.24 and resistance at $0.38, with a 30-day price range from $0.1775 to $0.3622.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.23 | $0.264 | $0.3392 | 0% | Neutral | |
| $0.2051 | $0.2814 | $0.4173 | +7% | Neutral | |
| $0.2566 | $0.3745 | $0.5927 | +42% | Bullish | |
| $0.2421 | $0.3724 | $0.6191 | +41% | Bullish | |
| $0.2542 | $0.4099 | $0.7097 | +55% | Bullish | |
| $0.2112 | $0.356 | $0.6383 | +35% | Bullish | |
| $0.159 | $0.2796 | $0.517 | +6% | Neutral | |
| $0.1977 | $0.3621 | $0.6882 | +37% | Bullish | |
| $0.2316 | $0.4413 | $0.8601 | +67% | Bullish | |
| $0.2418 | $0.479 | $0.9554 | +81% | Bullish | |
| $0.2338 | $0.5195 | $1.14 | +97% | Bullish | |
| $0.355 | $0.7889 | $1.81 | +199% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.23 | $0.264 | $0.3024 | +0.00% |
| September 2026 | $0.2016 | $0.245 | $0.3107 | -7.19% |
| October 2026 | $0.2183 | $0.2691 | $0.3482 | +9.83% |
| November 2026 | $0.2161 | $0.2694 | $0.3543 | +0.11% |
| December 2026 | $0.2018 | $0.2542 | $0.3392 | -5.64% |
Click any year to see its month-by-month AIM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AIM could reach as high as $0.3392, with a base case around $0.264 and support toward $0.23 — roughly 0% from $0.264. Price action looks broadly range-bound.
Expect AIM to range from $0.2051 to $0.4173 through 2027. The $0.2814 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
The AIM price prediction for 2028 points to an average of $0.3745 (low $0.2566, high $0.5927) — a potential gain of +42% on today's $0.264. Momentum favours further upside here.
In 2029, AIM is projected to trade between $0.2421 and $0.6191, averaging $0.3724 — a potential gain of +41% from today's $0.264. That is -1% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
AIM ImmunoTech Inc.'s 2030 outlook centres on $0.4099, within a $0.2542 to $0.7097 range. That is up +10% on the projected 2029 average. That marks a +55% change versus current levels. Momentum favours further upside here.
By 2031, AIM could reach as high as $0.6383, with a base case around $0.356 and support toward $0.2112 — roughly +35% from $0.264. Buyers look set to stay in control over this stretch.
Expect AIM to range from $0.159 to $0.517 through 2032. The $0.2796 average target implies a +6% move from current prices. That is -21% versus the projected 2031 average. Price action looks broadly range-bound.
The AIM price prediction for 2033 points to an average of $0.3621 (low $0.1977, high $0.6882) — a potential gain of +37% on today's $0.264. Buyers look set to stay in control over this stretch.
In 2034, AIM is projected to trade between $0.2316 and $0.8601, averaging $0.4413 — a potential gain of +67% from today's $0.264. That is up +22% on the projected 2033 average. Momentum favours further upside here.
AIM ImmunoTech Inc.'s 2035 outlook centres on $0.479, within a $0.2418 to $0.9554 range. That is up +9% on the projected 2034 average. That marks a +81% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, AIM could reach as high as $1.14, with a base case around $0.5195 and support toward $0.2338 — roughly +97% from $0.264. Momentum favours further upside here.
Expect AIM to range from $0.355 to $1.81 through 2050. The $0.7889 average target implies a +199% move from current prices. That is up +52% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in AIM today (≈ 3,787.878788 AIM) could be worth
$2,988.16
+$1,988.16 (+199%) by 2050 · US Dollar
Based on the average projected AIM price of $0.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AIMwould be worth at today's price.
$1,000 invested in AIM on Jul 31, 2025 (≈ 353.082165 AIM) would be worth
$93.21
-$906.79 (-90.7%) today · 0.09× · US Dollar
Based on a AIM entry price of $2.83 vs. today's $0.264.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.25 | $1,056 | +5.6% |
| 1 month ago | $0.3 | $880 | -12.0% |
| 3 months ago | $0.52 | $507.69 | -49.2% |
| 6 months ago | $1.17 | $224.95 | -77.5% |
| 1 year ago | $2.83 | $93.21 | -90.7% |
| All time (5.0y) ago | $200.78 | $1.31 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AIM forecast.
Our base-case forecast reaches $0.53 around 2050.
Implied market cap at $0.53: $14.69M
The multi-year forecast shows bullish momentum with rising averages: 2030 avg $0.3943 and ROI 55.5%; 2040 avg $0.4986 and ROI 96.6%; 2050 avg $0.7582 and ROI 199%.
Notable earlier bullish years include 2028 avg $0.3597 and ROI 41.8%; 2029 avg $0.3579 and ROI 41.1%; 2034 avg $0.4237 and ROI 67.1%; 2035 avg $0.4597 and ROI 81.3%.
2032 carries a neutral sentiment with ROI 5.8% (avg $0.2684).
These are estimates and not guarantees, reflecting the provided projections and associated uncertainty.
Tap a question to reveal the answer.
Avg $0.3943; Min $0.2445; Max $0.6828; ROI 55.5; Sentiment BULLISH.
Forecasts show neutral in 2026-2027 then bullish from 2028 onward, with 2030–2050 averages rising to as high as $0.7582 by 2050 and ROI up to 199 by 2050. Current price is $0.2536 and market cap $7.03M; these are estimates, not guarantees.
Yes, the forecast maximum by 2050 is $1.74, indicating a potential to surpass $1 according to the provided numbers.
Current price $0.2536; market cap $7.03M.
RSI14 is 40; SMA50 is $0.356; SMA200 is $0.9348; support at $0.24; resistance at $0.38; 30-day range from $0.1775 to $0.3622.
AIM ImmunoTech Inc. Community Discussion
0Share your AIM ImmunoTech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.